Literature DB >> 3989301

Serum transfer of collagen arthritis in congenitally athymic nude rats.

K Takagishi, N Kaibara, T Hotokebuchi, C Arita, M Morinaga, K Arai.   

Abstract

The role of cellular immunity in collagen arthritis was investigated with congenitally athymic nude rats (rnu/rnu) and their heterozygous littermates (rnu/+). Immunization with type II collagen induced polyarthritis and definite immunity to type II collagen in rnu/+ rats, whereas rnu/rnu rats did not develop arthritis or immunity to collagen. An additional study demonstrated that collagen arthritis could be passively transferred with a serum concentrate from arthritic Sprague-Dawley rats to naive rnu/rnu rats as well as to rnu/+ rats. Histopathologically, the passively transferred arthritis in rnu/rnu rats resembled that in rnu/+ rats. Despite no difference in clearance of anti-type II collagen antibody after transfer between them, the passively transferred arthritis in rnu/rnu rats was significantly enhanced and prolonged in comparison with that in rnu/+ rats. These results indicate that arthritis may be inducible by humoral immunity in the absence of functional T cells and also suggest that anti-type II collagen-antibody is not the sole regulatory factor and that the suppressor cell system might regulate the clinical course of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989301

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Induction of erosive arthritis in mice after passive transfer of anti-type II collagen antibodies.

Authors:  N Loutis; P Bruckner; A Pataki
Journal:  Agents Actions       Date:  1988-12

2.  Cia25 on rat chromosome 12 regulates severity of autoimmune arthritis induced with pristane and with collagen.

Authors:  Max Brenner; Teresina Laragione; Adriana Mello; Pércio S Gulko
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

3.  Effect of etodolac on type-II collagen-induced arthritis in mice.

Authors:  K Inoue; A Motonaga; H Suzuka; H Yoshifusa; H Fujisawa; T Nishimura; Y Inoue; F Ueda; Y Shibata; K Kimura
Journal:  Agents Actions       Date:  1993-07

4.  Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis.

Authors:  M C Boissier; X Z Feng; A Carlioz; R Roudier; C Fournier
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

5.  Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes.

Authors:  Kutty Selva Nandakumar; Lars Svensson; Rikard Holmdahl
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

6.  Therapeutic effects of estradiol benzoate on development of collagen-induced arthritis (CIA) in the Lewis rat are mediated via suppression of the humoral response against denatured collagen type II (CII).

Authors:  Y Waksman; I Hod; A Friedman
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

7.  Comparative study of effects of cyclosporins A and G on collagen arthritis in mice.

Authors:  K Takagishi; M Yamamoto; H Miyahara; T Hotokebuchi; N Kaibara
Journal:  Agents Actions       Date:  1992-11

8.  Quantitative dynamic models of arthritis progression in the rat.

Authors:  Justin C Earp; Debra C Dubois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2008-08-30       Impact factor: 4.200

9.  Effects of cyclosporin on collagen induced arthritis in mice.

Authors:  K Takagishi; N Kaibara; T Hotokebuchi; C Arita; M Morinaga; K Arai
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

10.  Homologous collagen-induced arthritis in rats and mice are associated with structurally different major histocompatibility complex DQ-like molecules.

Authors:  R Holmdahl; C Vingsbo; H Hedrich; M Karlsson; C Kvick; T J Goldschmidt; K Gustafsson
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.